Mindfully Curated
Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study finds. In statin users, screening did not increase the incidence of prostate cancer as it did in other men.
Researchers have made a major discovery in understanding motor neuron disease (MND). The research team has found that MND has 4 distinct patterns of changes in electrical signals that can be identified using EEG (electroencephalography).
The company’s plan to sell itself just got a little more complicated in a potentially good way.
By understanding the epidemiology and population biology of a significant and high-priority pathogen, Enteroccocus faecium (E. faecium) in Irish hospitals, researchers are providing the evidence base for more effective surveillance, and infection and p…
This Chinese automaker has garnered a significant following.
The stock of the luxury electric vehicle maker is up 165% in six months.
Investors wanting the next 75-bagger can learn a lot from these stocks.
The cryptocurrency is more than its token. Its other uses may make it more valuable.
Stock markets are trying to rebound after a steep drop last Friday.
These market leaders could make you richer in the long run.
Here’s what our real estate writers think about Zillow’s recent shake-up.
Should it take on more content for Peacock or license it?
Trupanion continues to compound its revenue at a high rate in an industry with a promising growth outlook.
The biotech is already hard at work developing a vaccine against the worrisome omicron variant.
These investments seem pretty vulnerable right now.
These two stocks have the potential to surprise investors next year.
After five years in the wilderness, LendingClub is back and better than ever.
The online dating company hops aboard the metaverse bandwagon.
The fintech has been a great performer, but could its recent pullback be an opportunity?
It doesn’t take a lot to own a piece of these rapidly growing healthcare businesses.